OptraSCAN: AI-Powered Cytology Platform Expands Access and Accuracy for Cervical Cancer Screening Across Asia—Aligned with WHO’s 90-70-90 Elimination Goals SINGAPORE, August 5, 2025 /EINPresswire.com/ -- OptraSCAN, a global leader in...

The World Health Organization (WHO) has awarded the Roche human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System and for self-collected samples on the cobas 5800, 6800 and 8800 Systems. These...

Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over...

How Motic Uses Digital Pathology to Combat Cervical Cancer Cervical cancer is considered a leading cause of cancer-related deaths among women worldwide. Let that sink in — a cancer that’s largely preventable by the HPV vaccine and, at...

Courtesy of colLABoration: A Sharing of Insights for Enhancing Laboratories and Laboratory Informatics Advisory Panel Recommends HPV as First-line Screen An advisory panel for the Medical Devices Committee of the FDA voted unanimously to...